Targeting heterogeneity in human Glioblastoma with mRNA-based Multispecific CAR-T Cells.

• Unité de recherche: INNOSUISSE
• Numéro de projet: 120.190 IP-LS
• Titre du projet anglais: Targeting heterogeneity in human Glioblastoma with mRNA-based Multispecific CAR-T Cells.

Mots-clé (Anglais)

Life sciences, Human medicine

Résumé des résultats (Abstract) (Anglais)

Cellula Therapeutics is dedicated to developing a multispecific, transient expression vector-based autologous CAR-T cell therapy for glioblastoma multiforme (GBM), a form of brain cancer with a median survival rate of less than 2 years after diagnosis.